Difficulty: Medium
Average Score: 93%
Practice
A patient on oral anticoagulant therapy is commenced on sulfamethoxazole-trimethoprim, double-strength twice daily. One may expect to see the INR
Correct answer
A
Rationale
Rationale:
The correct answer is A) If I only is correct (Increase). When a patient on oral anticoagulant therapy, like warfarin, is started on sulfamethoxazole-trimethoprim, an antibiotic, it can lead to an increase in the INR (International Normalized Ratio). Sulfamethoxazole-trimethoprim can inhibit the metabolism of warfarin, leading to increased levels of warfarin in the blood, which in turn can increase the INR, indicating a higher risk of bleeding.
Option B) If III only is correct (Remain unchanged) is incorrect because the interaction between sulfamethoxazole-trimethoprim and warfarin can lead to a change in the INR, not a status quo.
Option C) If I and II are correct (Increase and Decrease) is incorrect because the interaction is more likely to increase the INR due to decreased metabolism of warfarin, not decrease it.
Option D) If II and III are correct (Decrease and Remain unchanged) is incorrect because the INR is expected to increase as a result of the drug interaction, not remain unchanged or decrease.
Educational Context:
Understanding drug interactions is crucial in clinical practice to prevent adverse effects and ensure optimal patient outcomes. This scenario highlights the importance of monitoring patients closely when starting new medications, especially when they are on drugs with narrow therapeutic indices like oral anticoagulants. Healthcare providers need to be aware of potential interactions and their effects on commonly used medications to provide safe and effective care.
The correct answer is A) If I only is correct (Increase). When a patient on oral anticoagulant therapy, like warfarin, is started on sulfamethoxazole-trimethoprim, an antibiotic, it can lead to an increase in the INR (International Normalized Ratio). Sulfamethoxazole-trimethoprim can inhibit the metabolism of warfarin, leading to increased levels of warfarin in the blood, which in turn can increase the INR, indicating a higher risk of bleeding.
Option B) If III only is correct (Remain unchanged) is incorrect because the interaction between sulfamethoxazole-trimethoprim and warfarin can lead to a change in the INR, not a status quo.
Option C) If I and II are correct (Increase and Decrease) is incorrect because the interaction is more likely to increase the INR due to decreased metabolism of warfarin, not decrease it.
Option D) If II and III are correct (Decrease and Remain unchanged) is incorrect because the INR is expected to increase as a result of the drug interaction, not remain unchanged or decrease.
Educational Context:
Understanding drug interactions is crucial in clinical practice to prevent adverse effects and ensure optimal patient outcomes. This scenario highlights the importance of monitoring patients closely when starting new medications, especially when they are on drugs with narrow therapeutic indices like oral anticoagulants. Healthcare providers need to be aware of potential interactions and their effects on commonly used medications to provide safe and effective care.